Atenolol (Tenormin)

Atenolol, marketed under the brand name Tenormin among others, is a beta-1 selective adrenergic blocking agent widely used in feline medicine for the management of cardiac conditions, particularly hypertrophic cardiomyopathy (HCM). This medication has become one of the cornerstone treatments for cats with HCM and other cardiac diseases where reducing heart rate and myocardial oxygen demand is beneficial. Atenolol belongs to the beta-blocker class of medications, which work by blocking the effects of adrenaline and related stress hormones on the heart. While atenolol is a human medication used off-label in veterinary medicine, extensive clinical experience has established its efficacy and safety profile in feline patients.

The mechanism of action of atenolol involves selective blockade of beta-1 adrenergic receptors, which are predominantly located in the heart. By blocking these receptors, atenolol reduces the stimulatory effects of catecholamines (adrenaline and noradrenaline) on cardiac tissue. This results in decreased heart rate (negative chronotropic effect), reduced force of cardiac contraction (negative inotropic effect), and slowed electrical conduction through the atrioventricular node (negative dromotropic effect). For cats with HCM, these effects are particularly beneficial because slowing the heart rate allows more time for the thickened ventricle to fill with blood, improving cardiac output. Additionally, reduced myocardial oxygen demand helps protect the heart muscle from damage.

Atenolol is available in tablet form in various strengths, and oral suspension formulations are also available. The tablets can be divided to achieve appropriate doses for cats, though compounded liquid preparations are sometimes used for more precise dosing in small patients. The medication is typically administered once or twice daily, depending on the specific condition being treated and individual patient response. Atenolol has good oral bioavailability and can be given with or without food. The relatively small tablet sizes and availability of liquid formulations make dosing cats more manageable compared to some other cardiac medications.

The safety profile of atenolol in cats is generally favorable when prescribed appropriately under veterinary supervision. The medication has been used in feline medicine for decades, providing extensive clinical experience with its use. Most cats tolerate atenolol well, though side effects can occur, particularly if the dose is too high or if the cat has underlying conditions that make beta-blockade problematic. Your veterinarian will carefully evaluate your cat's cardiac function, often using echocardiography, before prescribing atenolol. Regular monitoring throughout treatment helps ensure the medication is providing therapeutic benefit while minimizing risks. Dose adjustments may be needed based on heart rate response and clinical status.

The primary indication for atenolol in cats is the management of hypertrophic cardiomyopathy, the most common form of heart disease in felines. HCM causes abnormal thickening of the heart muscle, particularly the left ventricular wall and interventricular septum, which impairs the heart's ability to relax and fill properly during diastole. Atenolol provides multiple benefits for cats with HCM by slowing the heart rate to allow more filling time, reducing myocardial oxygen demand, and decreasing the force of contraction which can help with dynamic outflow tract obstruction in some cases. For many cats with HCM, atenolol is considered a first-line medication, often initiated when the disease is diagnosed even before clinical signs develop.

Beyond HCM, atenolol is used to manage various tachyarrhythmias (abnormally fast heart rhythms) in cats. Supraventricular tachycardia, atrial fibrillation with rapid ventricular response, and ventricular premature complexes may respond to beta-blocker therapy. Atenolol helps control these arrhythmias by slowing conduction through the atrioventricular node and reducing the heart's responsiveness to stimulating hormones. For cats with arrhythmias, achieving rate control is important for preventing cardiac remodeling and heart failure. Your veterinarian or a veterinary cardiologist may recommend Holter monitoring or other diagnostic tests to evaluate arrhythmias and assess response to treatment.

Hyperthyroidism, a common endocrine disease in older cats, frequently causes cardiac effects including elevated heart rate, cardiac hypertrophy, and sometimes arrhythmias. Atenolol is often prescribed for hyperthyroid cats to control these cardiac manifestations while definitive treatment for the thyroid condition is being implemented or if definitive treatment cannot be pursued. The medication helps protect the heart from the excessive stimulation caused by elevated thyroid hormone levels. Once hyperthyroidism is successfully treated and thyroid levels normalize, atenolol may be gradually discontinued under veterinary supervision, or it may be continued if underlying cardiac disease is present.

Systemic hypertension in cats may be treated with atenolol as part of a multi-drug approach, though beta-blockers are not typically first-line therapy for feline hypertension. Atenolol may help lower blood pressure through its effects on heart rate and cardiac output. However, calcium channel blockers such as amlodipine are generally more effective for controlling feline hypertension. Atenolol may be added when additional blood pressure control is needed or when concurrent tachycardia requires management. The decision to include atenolol in a hypertension treatment protocol depends on the individual patient's cardiac status and response to other medications.

Veterinarians choose atenolol for feline patients based on the specific cardiac condition, the need for rate control, and individual patient characteristics. The beta-1 selectivity of atenolol is advantageous because it minimizes effects on beta-2 receptors in the airways, though at higher doses some beta-2 blockade can occur. Atenolol's long history of use in feline medicine provides confidence in its safety and efficacy. For cats undergoing stressful procedures or transport, atenolol may help prevent dangerous elevations in heart rate that could be harmful in the context of cardiac disease. Your veterinarian or veterinary cardiologist will determine whether atenolol is appropriate for your cat's specific condition.

Dosing of atenolol in cats is determined by your veterinarian based on careful evaluation of your cat's cardiac condition, heart rate, body weight, and overall health status. Because atenolol is used off-label in cats, dosing is based on extensive clinical experience and veterinary literature rather than FDA-approved feline labeling. The goal of therapy is typically to achieve a target resting heart rate while maintaining adequate cardiac output. Your veterinarian may use echocardiography and electrocardiography to guide dosing decisions. Accurate body weight is essential, and your cat should be weighed at each veterinary visit to ensure appropriate dosing as weight changes occur.

Typical dosing protocols for atenolol in cats generally involve once or twice daily oral administration. Twice-daily dosing provides more consistent beta-blockade throughout the day and is often preferred, particularly for cats with significant arrhythmias or severe HCM. Starting doses are usually conservative, with gradual increases while monitoring heart rate response and clinical status. The target heart rate varies depending on the underlying condition but typically aims for adequate rate control without excessive bradycardia. Your veterinarian will assess your cat's response and adjust the dose as needed to achieve therapeutic goals while minimizing side effects.

Treatment duration with atenolol depends on the underlying condition being managed. For cats with HCM or other chronic cardiac conditions, atenolol therapy is typically lifelong, as these diseases are managed rather than cured. Hyperthyroid cats may receive atenolol temporarily while thyroid disease is being addressed, with potential discontinuation once euthyroidism is achieved. For cats with chronic arrhythmias, ongoing therapy is usually required. The duration of treatment is determined by your cat's specific condition and response to therapy. Regular veterinary monitoring is essential to assess continued need for treatment and to make dose adjustments as your cat's condition evolves.

Atenolol tablets can be given with or without food, though giving the medication at consistent times each day helps maintain stable drug levels. The tablets can be hidden in pill pockets, small amounts of canned food, or soft treats. Liquid compounded formulations can be administered directly by mouth using an oral syringe. For cats who are difficult to medicate, discuss alternative administration strategies with your veterinarian. Consistency in administration timing is particularly important for atenolol because the medication's effects on heart rate must be maintained throughout the day. Missing doses can result in rebound tachycardia.

If you miss a dose of atenolol, give it as soon as you remember unless it is almost time for the next dose. In that case, skip the missed dose and continue with the regular schedule. Never give a double dose, as excessive beta-blockade can cause dangerous bradycardia or hypotension. For cats with significant cardiac disease, missed doses of atenolol can be problematic because sudden withdrawal of beta-blockade may cause rebound increases in heart rate. Try to maintain consistent daily administration by setting reminders or linking medication time to routine activities. Contact your veterinarian if you have missed multiple doses.

Never discontinue atenolol abruptly without veterinary guidance. Sudden withdrawal of beta-blocker therapy can cause dangerous rebound effects including tachycardia and potentially worsening of underlying cardiac conditions. If atenolol needs to be discontinued, your veterinarian will recommend a gradual dose reduction schedule to safely wean your cat off the medication. If you have concerns about side effects or difficulty administering the medication, discuss these with your veterinarian before making any changes. Your veterinarian can help find solutions while ensuring your cat's cardiac condition remains properly managed.

Atenolol is generally well-tolerated in most cats when prescribed at appropriate doses under proper veterinary supervision. The medication has been used extensively in feline cardiac medicine, providing considerable clinical experience regarding its safety profile. Most cats with HCM or other cardiac conditions benefit from atenolol therapy with minimal adverse effects. However, side effects can occur, particularly if the dose is too high or if the cat has conditions that make beta-blockade problematic. Understanding potential side effects allows cat owners to monitor appropriately and seek veterinary attention when needed.

The most commonly observed side effects of atenolol relate to its intended pharmacological effects when they become excessive. Bradycardia (abnormally slow heart rate) can occur if the dose is too high, manifesting as lethargy, weakness, or exercise intolerance. Mild lethargy is relatively common when starting atenolol therapy and often improves as the cat adjusts to the medication. Decreased appetite and gastrointestinal disturbances including occasional vomiting or diarrhea may occur. Hypotension (low blood pressure) may develop, causing weakness, wobbliness, or collapse in severe cases. Many of these effects are dose-dependent and resolve with dose adjustment.

Moderate side effects warranting veterinary consultation include persistent lethargy that does not improve after the initial adjustment period, significant appetite reduction or weight loss, signs of depression or behavioral changes, and cold extremities suggesting poor peripheral circulation. Because beta-blockers can affect glucose metabolism, diabetic cats or those at risk for diabetes should be monitored more closely. Some cats may experience worsening of respiratory conditions if beta-2 blockade occurs at higher doses. Changes in your cat's usual behavior, activity level, or demeanor should be reported to your veterinarian for evaluation.

Serious side effects requiring immediate veterinary attention are less common but can occur. Severe bradycardia may cause collapse, profound weakness, or syncope (fainting). Complete heart block or other serious conduction disturbances can develop in susceptible cats. Severe hypotension may manifest as collapse, pale gums, or unresponsiveness. Acute heart failure can occur if the negative inotropic effects of atenolol are too pronounced for a particular patient's cardiac status. Allergic reactions, while rare, may include facial swelling, hives, or difficulty breathing. Seek immediate veterinary care if your cat experiences any of these serious symptoms.

Rare side effects and long-term considerations include potential effects on lipid metabolism and theoretical concerns about masking signs of hypoglycemia in diabetic cats. Long-term use of atenolol is generally considered safe with appropriate monitoring, and many cats receive the medication for years without significant problems. Your veterinarian will recommend periodic examinations and diagnostic testing to monitor your cat's cardiac status and response to therapy. Report any unusual symptoms or changes in your cat's condition to your veterinarian, even if they seem minor or unrelated to heart medication.

Atenolol is contraindicated in cats with certain cardiac conditions where beta-blockade would be harmful. Cats with significant bradycardia (already slow heart rate) should not receive atenolol as it could further reduce heart rate to dangerous levels. Atrioventricular (AV) block greater than first-degree is a contraindication because beta-blockers can worsen conduction abnormalities. Sick sinus syndrome, characterized by dysfunction of the heart's natural pacemaker, contraindicates atenolol use. Cats in acute decompensated heart failure should not receive atenolol until they are stabilized, as the negative inotropic effects could worsen cardiac output in the acute setting. Your veterinarian will perform appropriate cardiac evaluation before prescribing atenolol.

Cats with severe hypotension should not receive atenolol as it may further lower blood pressure. Cardiogenic shock, a state of critically compromised cardiac output, is an absolute contraindication to beta-blocker therapy. Certain forms of cardiomyopathy where the heart is already severely weakened may not tolerate the negative inotropic effects of atenolol. Pheochromocytoma, a rare adrenal tumor, contraindicates beta-blocker monotherapy due to risk of hypertensive crisis from unopposed alpha-adrenergic stimulation. Your veterinarian will assess your cat's cardiovascular status to determine if atenolol is appropriate and safe.

Respiratory conditions may represent relative contraindications to atenolol use. While atenolol is beta-1 selective, some beta-2 blockade can occur at higher doses, potentially causing bronchospasm in susceptible cats. Cats with significant asthma or chronic bronchitis should be evaluated carefully before receiving atenolol, and alternative medications may be preferred. Severe pulmonary disease may also affect the decision to use beta-blockers. If atenolol is deemed necessary despite respiratory concerns, careful dose titration and close monitoring for respiratory side effects are essential.

Additional contraindications and precautions include known hypersensitivity to atenolol or other beta-blockers. Cats with severe renal impairment may require dose adjustment since atenolol is partially eliminated through the kidneys. Diabetic cats require careful monitoring as beta-blockers can affect glucose metabolism and may mask signs of hypoglycemia. Pregnant cats should not receive atenolol unless the benefits clearly outweigh risks, as beta-blockers can affect fetal development. Always provide your veterinarian with a complete medical history including all current and past health conditions to ensure atenolol is safe for your individual cat.

Informing your veterinarian of all medications, supplements, and over-the-counter products your cat receives is essential before starting atenolol therapy. Drug interactions can significantly alter how atenolol works, potentially causing additive effects that increase side effects or antagonistic effects that reduce efficacy. Even products that seem harmless may interact with beta-blockers. Maintaining a comprehensive list of everything your cat takes ensures your veterinarian can prescribe atenolol safely. Always consult your veterinarian before adding any new medication or supplement while your cat is receiving atenolol.

Several significant drug interactions exist between atenolol and other medications commonly used in veterinary medicine. Concurrent use of calcium channel blockers, particularly verapamil or diltiazem, with atenolol can cause additive negative effects on heart rate and cardiac conduction, potentially leading to severe bradycardia or heart block; this combination requires careful monitoring if used. Other antihypertensive medications may have additive blood pressure-lowering effects. Digoxin combined with atenolol increases the risk of bradycardia and AV block. Anesthetic agents may have enhanced cardiovascular depressant effects in patients receiving beta-blockers. NSAIDs may reduce the antihypertensive effects of atenolol and should be used cautiously.

Medications affecting the sympathetic nervous system can interact with atenolol. Clonidine withdrawal in patients receiving beta-blockers can cause rebound hypertension. Sympathomimetic drugs like phenylpropanolamine may have reduced effectiveness or altered effects when combined with beta-blockers. Thyroid hormone supplementation in hypothyroid cats receiving atenolol may require dose adjustment of the beta-blocker. If your cat receives any medications affecting heart rate, blood pressure, or cardiac function, discuss potential interactions with your veterinarian before starting atenolol.

Monitoring for drug interactions involves regular veterinary examinations and appropriate diagnostic testing. Heart rate monitoring at home and during veterinary visits helps detect excessive bradycardia from drug interactions. Blood pressure measurement may be indicated when multiple cardiovascular medications are used. Electrocardiography can detect conduction abnormalities that might result from drug interactions. Signs of potential interactions include unexpected changes in heart rate, profound lethargy, weakness, fainting, or reduced medication effectiveness. Contact your veterinarian promptly if you notice unusual symptoms after starting any new medication. Never adjust atenolol dosing without veterinary guidance.

General precautions for atenolol use in cats include ensuring accurate weight-based dosing, strict adherence to veterinary instructions, and commitment to regular monitoring appointments. Heart rate monitoring is particularly important for cats receiving atenolol, and your veterinarian may teach you to check your cat's heart rate at home. Never alter the prescribed dose without veterinary guidance, as both underdosing and overdosing can have significant consequences. Store atenolol safely away from pets and children, and use the medication only for the cat for whom it was prescribed. Beta-blocker requirements vary significantly between individual patients, so never share cardiac medications between pets.

Breed-specific considerations are highly relevant for atenolol therapy given the hereditary nature of many feline cardiac conditions. Maine Coon cats have well-documented genetic predisposition to hypertrophic cardiomyopathy and may require atenolol as part of disease management. Ragdoll cats carry similar HCM genetic risk. British Shorthairs, Persians, Sphynx, Bengal, and Devon Rex breeds also have elevated HCM prevalence. These breeds benefit from cardiac screening (echocardiography) to detect disease early, and affected cats may be started on atenolol based on disease severity. Some breeds may have variations in drug metabolism, though specific pharmacogenomic data for atenolol in different cat breeds is limited.

Environmental and handling precautions include proper storage and safe administration practices. Keep atenolol in its original container, protected from light, moisture, and temperature extremes. Wash hands after handling the medication. In multi-pet households, ensure only the intended patient receives the medication and that other animals cannot access tablets. While atenolol is not highly toxic to humans at single-dose exposures, accidental ingestion can cause cardiovascular effects, and medical attention should be sought. Keep medications secure from children who might mistake tablets for candy.

Monitoring during atenolol therapy should include regular assessment of heart rate, activity level, appetite, and overall well-being. Learning to check your cat's resting heart rate at home provides valuable information for your veterinarian. Watch for signs of excessive beta-blockade including profound lethargy, weakness, very slow heart rate, or fainting. Also monitor for improvement in signs that prompted treatment initiation. Your veterinarian will establish a monitoring schedule that may include periodic electrocardiography, echocardiography, and physical examinations. Report any concerns about your cat's condition promptly.

Special populations requiring additional caution include geriatric cats, who may be more sensitive to beta-blocker effects and may have age-related kidney function decline affecting drug elimination. Diabetic cats require careful monitoring as atenolol can affect glucose metabolism and may mask hypoglycemia symptoms. Cats with thyroid disease, particularly those transitioning from hyperthyroid to euthyroid status, may need atenolol dose adjustments. Cats with any degree of renal impairment may require modified dosing. Very young kittens have limited safety data for atenolol use. Always provide your veterinarian with complete information about your cat's health history.

Proper storage of atenolol is essential to maintain medication effectiveness throughout the treatment period. Tablets should be stored at controlled room temperature, typically between 68°F and 77°F (20°C to 25°C), protected from excessive heat, cold, light, and moisture. Keep the medication in its original container with the cap tightly secured. Avoid storing atenolol in bathrooms or kitchens where humidity fluctuates, or near windows where light exposure is increased. Do not store the medication in vehicles where temperatures can reach extremes. The light-sensitive nature of atenolol makes proper storage particularly important for maintaining potency.

Formulation-specific storage requirements may apply depending on the product form. Standard atenolol tablets are generally stable when stored properly at room temperature. If your veterinarian has prescribed a compounded oral suspension, it may require refrigeration and will typically have a shorter shelf life than commercial tablets; follow the specific storage instructions provided by the compounding pharmacy carefully. Always check expiration dates before administering medication, and do not use products past their labeled expiration, as drug potency cannot be guaranteed. Inspect tablets for discoloration, unusual odor, or deterioration before use; if tablets appear abnormal, contact your pharmacist.

Safe handling and disposal practices protect household members and the environment. Store atenolol in a secure location inaccessible to children and pets. Accidental ingestion of atenolol by children or other pets can cause significant cardiovascular effects including bradycardia and hypotension. Pregnant women do not need to avoid handling atenolol, but should wash hands after contact with any medication. For disposal of unused or expired atenolol, do not flush down toilets or pour down drains. Utilize pharmacy or veterinary clinic drug take-back programs when available. If no take-back option exists, mix tablets with undesirable substances like coffee grounds or cat litter in a sealed bag before placing in household trash, following current FDA disposal guidelines.

Breed considerations are particularly important for atenolol therapy due to the hereditary nature of hypertrophic cardiomyopathy, the primary indication for this medication in cats. Certain purebred cat breeds have well-documented genetic predispositions to HCM, making atenolol a commonly prescribed medication in these populations. Understanding breed-specific cardiac risks helps guide screening recommendations and treatment decisions. Your veterinarian considers breed as a significant factor when evaluating cats for cardiac disease and determining appropriate management strategies, while recognizing that HCM can occur in any cat regardless of breed.

Maine Coon cats have the most extensively studied genetic basis for HCM, with identified mutations in the MYBPC3 gene (cardiac myosin binding protein C) linked to disease development. Genetic testing is available for Maine Coons to identify carriers of the A31P mutation. Ragdoll cats carry a different MYBPC3 mutation (R820W) also associated with HCM. For cats of these breeds, genetic testing and echocardiographic screening are recommended, with affected cats potentially benefiting from early atenolol therapy. British Shorthairs, Persians, Sphynx, Bengal, Devon Rex, and Scottish Fold breeds also demonstrate elevated HCM prevalence compared to the general cat population.

Body size affects atenolol dosing across different breeds. Large breeds such as Maine Coons, Norwegian Forest Cats, and Ragdolls may require higher total doses while remaining within appropriate weight-based ranges. Very small cats require precise dosing to avoid excessive beta-blockade, and compounded liquid formulations may facilitate accurate dosing for small patients. The available tablet strengths may not divide evenly into ideal doses for all cat sizes. Regardless of breed or size, accurate current body weight is essential for appropriate dosing, and weight should be measured at each veterinary visit.

Age interacts with breed factors for cats receiving atenolol. Cardiac disease can develop at any age but is often diagnosed in middle-aged to older cats. However, in breeds with genetic HCM predisposition, disease may develop at younger ages, and screening echocardiography is often recommended starting at one to two years of age. Senior cats may be more sensitive to atenolol's effects and may require dose adjustments. Some purebred lines have shorter life expectancies due to cardiac disease, while early diagnosis and treatment may help improve outcomes. Your veterinarian will develop an individualized screening and treatment plan based on your cat's breed, age, and cardiac status.

Other beta-blockers used in feline medicine include propranolol, a non-selective beta-blocker, and sotalol, which has both beta-blocking and antiarrhythmic properties. Propranolol was historically used before atenolol became preferred due to atenolol's beta-1 selectivity and longer duration of action. Sotalol may be selected for cats with specific arrhythmias requiring its unique class III antiarrhythmic effects. Carvedilol, a non-selective beta-blocker with alpha-blocking properties, is occasionally used for cats with heart failure. The choice between beta-blockers depends on the specific cardiac condition, presence of arrhythmias, and individual patient factors. Your veterinarian or veterinary cardiologist will select the most appropriate beta-blocker for your cat's needs.

Other medication classes are frequently used alongside or instead of atenolol depending on the cardiac condition. Calcium channel blockers such as diltiazem may be used for cats with HCM, particularly when rate control is needed and beta-blockers are contraindicated or insufficient. ACE inhibitors like benazepril or enalapril are often prescribed for cats with cardiac disease to reduce cardiac workload through vasodilation. Diuretics such as furosemide are essential for managing fluid accumulation in cats with congestive heart failure. Antiplatelet medications like clopidogrel are frequently prescribed for cats with enlarged left atria to reduce the risk of arterial thromboembolism. Pimobendan may be used for certain types of cardiomyopathy.

Complementary approaches may support cats receiving atenolol for cardiac disease. Omega-3 fatty acid supplements may provide some cardiovascular benefits. Low-sodium prescription diets are often recommended for cats with heart disease to help manage fluid balance. Taurine supplementation is important for cats with dilated cardiomyopathy, though this condition is less common since taurine fortification of commercial cat foods. Stress reduction is important for cats with cardiac disease, as stress can trigger dangerous heart rate elevations. Never substitute any medication or supplement for prescribed atenolol without explicit veterinary approval. Cardiac disease management requires coordinated care, and your veterinarian should be informed of all products your cat receives.